Loading Events
This event has passed.

ISA Virtual Workshop
Screening For ATTR Amyloidosis: Who, How, When?

ATTR amyloidosis is a frequently unrecognised but increasingly important cause of cardiomyopathy and neuropathy. While relatively uncommon compared to other aetiologies, identification of ATTR in earlier stage of disease is critical to permit available therapies the best efficacy. Despite its importance, a general consensus regarding the most practical approaches toward screening of at-risk patients for ATTR amyloidosis is lacking.

This workshop will address controversies regarding screening for ATTR amyloidosis, particularly relevant to internists, neurologists, and cardiologists. Best practices for screening will be suggested. Following three recorded presentations, a live, 15-minute, moderated discussion will be held to answer viewers submitted questions.

Learn from ISA experts about best practices for screening. Bring your questions!

Frederick L. Ruberg, MD, Workshop Moderator.

View speakers Bios: https://www.isaamyloidosis.org/meetings-education/isa-virtual-workshop-screening-for-attr-amyloidosis-who-how-when/screening-for-attr-amyloidosis-speakers.php

Thursday, July 22, 2021
9 AM EDT (timezone converter)
Free, registration required